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Abstract
Background: MicroRNAs (miRNAs) have been recently involved in most of human diseases as targets for potential strategies
to rescue the pathological phenotype. Since the skeletal muscle is a spread-wide highly differentiated and organized tissue,
rescue of severely compromised muscle still remains distant from nowadays. For this reason, we aimed to identify a subset
of miRNAs major involved in muscle remodelling and regeneration by analysing the miRNA-profile of single fibres isolated
from dystrophic muscle, which was here considered as a model of chronic damage.
Methodology/Principal Findings: The miRNA-signature associated to regenerating (newly formed) and remodelling
(resting) fibres was investigated in animal models of muscular dystrophies and acute damage, in order to distinguish which
miRNAs are primary related to muscle regeneration. In this study we identify fourteen miRNAs associated to dystrophic
fibres responsible for muscle regeneration and remodelling, and confirm over-expression of the previously identified
regeneration-associated myomiR-206. In particular, a functional binding site for myomiR-206 was identified and validated in
the 39untranslated region (39UTR) of an X-linked member of a family of sequence independent chromatin-binding proteins
(Hmgb3) that is preferentially expressed in hematopoietic stem cells. During regeneration of single muscle fibres, Hmgb3
messenger RNA (mRNA) and protein expression was gradually reduced, concurrent with the up-regulation of miR-206.
Conclusion/Significance: Our results elucidate a negative feedback circuit in which myomiR-206 represses Hmgb3
expression to modulate the regeneration of single muscle fibres after acute and chronic muscle damage. These findings
suggest that myomiR-206 may be a potential therapeutic target in muscle diseases.
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Introduction
MiRNAs are a class of short non-coding RNAs that take part
in mastering the balance of gene-regulating networks by binding
to 39UTR of target mRNAs and inhibiting their expression [1].
The disclosure of these small RNA molecules introduced a new
labyrinthine dimension to gene regulation and gave the
opportunity to deepen our understanding on many biological
processes. MiRNAs were in fact demonstrated to be involved in
most of biological events and to finely regulate them [1,2]. Even
more importantly, they were found dysregulated in many diseases
[3,4,5,6,7,8] and apart from their specific role, their normaliza-
tion is considered a potential method of intervention in patients.
Focusing on the involvement of miRNAs in muscle development
and myogenesis, a restricted group of muscle-enriched miRNAs,
also called myomiRs (miR-1, miR-133, miR-206 and miR-208),
was demonstrated fundamental for muscle physiology and
plasticity [9,10,11]. In line with a growing characterization of
the myomiR network, researchers started to investigate the role of
miRNAs in muscle degeneration, which turns out to be very
challenging if considering the absence of an efficient therapy for
patients affected by most of primary muscular disorders. A
faithful model for studying muscle damage and regeneration, is
represented by muscular dystrophies (MDs) since they are a
group of diseases characterized by muscle wasting and weakness
due to defects in structural proteins expressed in the skeletal
muscle [12,13]. In particular MDs are proposed as two-tiered
diseases with acute large amount of myofibre necrosis resulting
from growth spurts or damaging exercise, superimposed upon a
background of a chronic low level of damage, with different
factors contributing to these two situations [14]. When Eisenberg
et al. analyzed the miRNome of muscle biopsies from patients
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affected by 10 major muscular disorders including MDs, 185
miRNAs were found to be differentially expressed in diseased
muscle [15]. This evidence introduced an additional dimension to
muscle degeneration, denouncing a strong participation of
miRNAs in muscle degeneration. Soon after this discovery,
Capogrossi and colleagues further investigated the role of
miRNAs in muscle damage by studying their expression profile
in an animal model of Duchenne Muscular Dystrophy (DMD),
the mdx mouse, and of acute ischemia [16]. This study
demonstrated a common signature of DMD and ischemic
muscle, outlining three different families of DMD-signature
miRNAs: inflammatory (miR-222 and miR-223), degenerative
(miR-1, miR-29c, and miR-135a) and regenerative (miR-31,
miR-34c, myomiR-206, miR-335, miR-449, and miR-494).
Finally, Cacchiarelli and colleagues demonstrated the mis-
regulation of several miRNAs in Duchenne condition (miR-1,
myomiR-133, miR-29 and miR-30) as consequence of differential
HCDAC nytrosilation state [17]. It is however important to
underline that whole-muscle based-analyses, as studies mentioned
above, supply a wide image of the miRNA-dysregulation
associated to damaged muscle without performing a deep analysis
of the muscular miRNAs involved in these processes. Dystrophic
muscle is in fact characterized by inflammatory infiltrations and
overcoming fibrotic- and adipose-tissue that progressively substi-
tute skeletal muscle [13]. The present study was addressed to
identify muscular miRNAs involved in muscle remodelling and
regeneration whose in vivo modulation might help recovering
from injury. In order to reach this aim, we initially profiled the
miRNome of single muscle fibres isolated from the mdx mouse.
The mdx mouse originates from a spontaneous mutation in exon
23 of the dystrophin gene resulting in a cyclic process of fibre
necrosis and regeneration, and giving rise to progressive muscle
wasting and replacement by connective and adipose tissue
[18,19,20]. Although the mdx mutants have a belated onset of
mild clinical symptoms compared with both Duchenne and
Becker muscular dystrophy, they have several histopathological
features in common [21,22]. We thus validate our miRNome
results in single muscle fibres isolated from other animal models
of MDs such as the alpha-Sgca-null and the FRG1 over-
expressing mice, respectively animal models of a limb-girdle 2D
(LMGD-2D) [23,24] and of Facioscapulohumeral dystrophy
(FSHD) [25]. The a-Sgca null mouse represents the first
engineered animal model for autosomal recessive MD with a
primary sarcoglycan gene defect [23]. Like the mdx mouse, the
main histological changes of a-Sgca-null muscles include exten-
sive central nucleation, increased variability of muscle fibre
diameter, and the persisted presence of degeneration and
regeneration [23]. Regarding muscle impairment, absence of a-
sarcoglycan was demonstrated to perturb more fast-twitch than
slow-twitch fibres. The FRG1 over-expressing mouse is a
transgenic mouse characterized by strong up-regulation of human
FRG1, causing muscular dystrophy similar to FSHD (abnormal
spinal curvature, progressive muscle dystrophy, skeletal muscle
atrophy, differential involvement of muscle types similar to
FSHD) [25]. Basing on several measurements (including fibre size
variation, number of internal nuclei, percentage of connective
tissue, number of necrotic fibres and number of regenerating
fibres), this animal model demonstrated different distribution of
muscle impairment. In particular, trapezius (TPZ) was defined as
the most affected muscle in FRG1 high over-expressing mice and
FSHD patients [25]. We also verified miRNAs associated to
regenerating single muscle fibres after acute damage. Strategies
that have been successfully used for this purpose include crush
[26], freeze [27], or chemically induced injury [28]. Perhaps the
most extensive and reproducible muscle injury is the delivery of
cardiotoxin (CTX; purified from the venom of the Naja nigricollis
snake) into the skeletal muscle of the mouse [28]. In this condition
it is possible to induce local acute muscle damage with a muscle
degeneration of about 80–90% [25] and a successive regenera-
tion which restore muscle integrity and homeostasis [29]. We
identify fourteen miRNAs associated to dystrophic fibres (miR-
15b, miR-17, miR-21, miR-27a, miR-31, miR-128a, miR-142-
5p, miR-199a-5p, miR-199b, miR199b*, miR-206, miR-221,
miR-223 and miR-335-5p) that may mediate muscle regeneration
and remodelling in animal models of MDs and acute muscle
damage, and confirm over-expression of the previously identified
regeneration-associated myomiR-206. Using a target-gene pre-
diction-analysis with 6 different computational algorithms (PITA,
TargetScan, PicTar, ElMMo, miRDb and miRanda), we
identified and validated a functional binding site for miR-206
in the 39 untranslated region (39UTR) of an X-linked member of
a family of sequence-independent chromatin-binding proteins
(Hmgb3) [30]. Importantly, Hmgb3 expression was reduced
during muscle regeneration concurrent with the up-regulation of
myomiR-206 in dystrophic muscle. All these data demonstrate for
the first time the involvement of Hmgb3, an Hmg-box family
transcription factor, in muscle regeneration.
Results
The miRNA Expression Profile of Dystrophic Muscle
Fibres Isolated from the Mdx Mouse
Since the mdx mouse originates from a spontaneous mutation
in exon 23 of the dystrophin gene and was previously
demonstrated to determine muscle pathophysiology of DMD
[18,19,20], we decided to investigated the role of miRNAs in
muscle remodelling by evaluating the miRNome of single muscle
fibres isolated from three different muscles (Tibialis Anterior,
TA; Diaphragm, DIA and Vastus, VA) of this animal model. We
selected different muscle tissues since the mdx mouse is
characterized by a heterogeneous distribution of muscle wasting
and weakness. As described, among the investigated muscles the
DIA was the most affected showing a pattern of degeneration/
regeneration, fibrosis comparable to the DMD muscle tissues
[31]. Adult 3K months-old mdx (n = 3) and c57bl (n = 3) mice
were sacrified and single muscle fibres were dissected from TA,
DIA and VA. The expression profile was performed by a
miRNA expression microarray (Miltenyi Biotech, Bergisch
Gladbach, Germany) containing probes matching for 584 mouse
miRNAs from the miRBase database (Figure 1A). For the
statistical analysis only miRNAs which had valid expression
values in at least two samples per muscle type were considered
and Two-class SAM (Significance Analysis of Microarrays)
method was used.
Fourteen miRNAs were found dysregulated in dystrophic
muscle fibres of the mdx mouse with differences linked to the
originating muscle (miR-206, miR-199a-5p, miR-223, miR-199b,
miR-199b*, miR-21, miR-221, miR-17, miR-15b, miR-31, miR-
128a, miR-142-5p, miR-335-5p and miR-27a). Importantly,
single muscle fibres isolated from the most affected DIA muscle
showed 13 miRNAs out of the 14 dys-regulated miRNAs
(Figure 1). Otherwise, single muscle fibres isolated from lower
affected TA and VA of the mdx mouse were respectively
associated to 7 (miR-206, miR-199a-5p, mir-223, mir-199b, miR-
199b*, miR-21 and miR-221) and 5 (miR-206, miR-199a-5p,
mir-223, mir-199b and miR-199b*) dysregulated miRNAs
(Figure 1). The array analysis evidenced a dystrophic miRNA-
signature not dependent to the muscle type of origin which
Hmgb3 Determine Muscle Regeneration
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include the regeneration-associated miR-206; miR-199a-5p,
miR-199b, miR-199b* and miR-223. These data are in
agreement with data already published on the involvement of
miRNAs in mdx and DMD muscle [15,16,17]. Otherwise, the
expression profile of miR-21 and miR-221 was strictly related to
the muscle type of origin (TA and DIA) (Figure 1). MiR-15b,
miR-17, miR-31, miR-128a, miR-142-5p and miR-335-3p were
specifically induced in single muscle fibres of dystrophic DIA
(Figure 1). Finally, miR-27a was only over-expressed when the
statistical analysis was performed independently of the muscle
type (Figure 1).
Validation of Microarray Results by Absolute Q-PCR
Analysis
Data obtained by the microarray analysis were validated by
absolute Q-PCR analyses. Absolute quantification confirmed
common up-regulation of miR-206, miR-199a-5p, miR-223 and
miR-199b* in all mdx single fibres tested (Figure S1). MiR-199b
dysregulation was statistically significant only in single muscle
fibres of dystrophic TA (Figure S1A), nevertheless an increment
was observed in fibres of dystrophic DIA and VA. A more
accurate and sensible quantification of miRNAs by Q-PCR
analysis, extended the miRNA signature common to dystrophic
single fibres of TA, DIA and VA to miR-128a, miR-31 and miR-
Figure 1. MiRNA profile of single fibres isolated from the mdx mouse. (A) Clustered heat map showing the expression ratios of miRNAs in
TA, DIA and VA of age- and sex-matched c57bl (n = 3) and mdx (n = 3) mice. Expression data were normalized on Universal Reference. A total of 14
miRNAs were found over-expressed in dystrophic samples with distinction among myofibres isolated from different muscle type. (B) Fold change
values of the 14 up-regulated miRNAs were reported in the table (ns = no significant).
doi:10.1371/journal.pone.0043464.g001
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142-5p (Figure S1). Importantly, up-regulation of miR-128a and
miR-31 in dystrophic single muscle fibres is strongly supported by
their recently discovered involvement in MDs and myogenesis
[32,33]. As shown in Figure S1, dysregulation of miR-15b was
extended to TA of the mdx mouse and higher expression levels of
miR-221 and miR-335-5p were confirmed in dystrophic DIA.
Finally, according to the array analysis, miR-27a over-expression
was statistically significant only when the analysis was performed
independently of the muscle type. In contradiction with the array
analysis, Q-PCR experiments evidenced i) up-regulation of miR-
21 in single muscle fibres isolated from VA and DIA of the mdx
mouse; ii) up-regulation of miR-221 limited to dystrophic DIA;
and iii) down-regulation of miR-17 in all dystrophic single muscle
fibres analyzed (more than 30 folds) (Figure S1). In conclusion, a
more sensible and specific quantification of miRNAs by absolute
Q-PCR analysis highlighted common up-regulation of miR-206,
miR-223, miR-199a-5p, miR-199b*, miR-27a, miR-128a, miR-31
and miR-142-5p, and down-regulation of miR-17 in dystrophic
fibres isolated from TA, DIA and VA of the adult mdx mouse
(Figure S1). Otherwise the expression profile of miR-15b, miR-
221, miR-21, miR-199a and miR-335-5p was strictly related to the
muscle-type considered (Figure S1).
Absolute quantification was also performed for miR-1, miR-133
and miR-181 because their expression profiles were formerly
investigated in dystrophic muscle and their dysregulation in the
mdx mouse was often controversial [10,16,17,34]. In particular,
their expression profiles seemed to strongly depend on the muscle
type and age of the mdx mouse [10,16,17,34]. When we
quantified these miRNAs in muscle fibres isolated from TA,
DIA and VA of adult mdx mice (3K m-o; n= 10), we did not
evidence differences between dystrophic and control muscle fibres
(Figure S1), as previously highlighted by the array analysis.
Since quantification of miRNAs by absolute Real-time PCR (Q-
PCR) analysis represents an innovative and original method, we
chose a relative quantification approach (qRT-PCR) to confirm
data obtained. With this approach the expression of miRNAs was
compared to invariable RNAU6 (normalizing factor) using a
comparative CT method. As shown in Figure S2, the miRNA
signature associated to mdx muscle fibres was confirmed by qRT-
PCR analyses (Figure S2). Basing on this evidence, forthcoming
quantification of miRNAs was performed only by Q-PCR
analyses.
Expression of Muscle-fibres Associated miRNAs during
Disease Progression of the Mdx Mouse
In order to verify if the miRNA-dysregulation observed in single
fibres of adult mdx mouse (3K months-old) was associated to
dystrophin absence, we isolated single muscle fibres from newborn
mdx mice, which exhibit a better histological pattern than older 6
month-old mdx mice [35]. The mdx mouse is in fact characterized
by progressive muscle deterioration due to increasing muscle loss
and overcoming fibrosis [36]. Single fibres were dissected from the
hind limb of newborn mdx (n = 10) and c57bl (n = 10) mice and
from TA, DIA and VA of 6 moth-old mdx mice (n = 10). The
expression levels of miRNAs were evaluated by absolute Q-PCR
analysis. The statistical analysis did not evidence dysregulated
miRNAs in newborn mdx muscle fibres, demonstrating any
correlation with the genetic defect causing DMD and a strong
association with accumulating degenerative/regenerative events
(Figure 2B) Otherwise, analyses performed on older mdx mice
showed a heterogeneous dysregulation of miRNAs. In particular,
some miRNAs decreased to control levels in old mdx mice (miR-
15b, miR-17, miR-31 and miR-128a) (Figure 2B), suggesting a
major involvement in compensatory mechanisms activated by the
muscle in the early step of disease. The expression levels of miR-
21, miR-142-5p, miR-199a-5p, miR-199b*, miR-206, miR-223
and miR-335-5p were instead strictly related to the type of muscle
considered, underling a relationship with muscle-type dependent
impairment (Figure 2B). Finally miR-27a was found over-
expressed in all muscle fibres analyzed (Figure 2B) and was
recently demonstrated to down-regulate the expression of 2
fundamental myogenic transcription factors (paired box proteins
PAX3 and PAX7) involved in the regulation of myogenesis and
muscle development [37]. Interestingly the expression profile of
miR-199b was shown parallel to disease progression, suggesting a
strong correlation with the quality of resting dystrophic muscle or
with accumulating muscle damage and fibrosis. Finally, miR-221
was characterized by an opposite trend of expression in adult (3K
m-o) and old (6 m-o) mdx mice respect control mice suggesting a
double function of this miRNA during DMD pathogenesis
(Figure 2B) which could be related to the muscle commitment
and differentiation, as previously described [38].
Chronic Damage Activates the miRNA Machinery in MDs
Since dystrophic muscle fibres isolated from the mdx mouse
exhibit a miRNA dysregulation that does not correlate with the
genetic defect and is strictly related to muscle remodelling (resting
fibres) and regeneration (newly-formed muscle fibres), we expected
to observe a similar dysregulation in the animal models of other
MDs. In this optic, we evaluated the previously tested miRNAs in
an animal model of LMGD-2D (the a-Sgca null mouse) and with
dystrophy similar to FSHD (the FRG1 high over-expressing
mouse). Mice were chosen age- and sex-matched and the analysis
included single muscle fibres isolated from different muscle types.
We selected the less and the most affected muscles depending on
the animal model: for the a-Sgca null mouse, we considered
respectively soleus (SOL) and the extensor digitorum longus
(EDL); for the FRG1 over-expressing mouse we analyzed
respectively VA and TPZ. Furthermore, since DIA is mildly
compromised in both animal models and was previously analyzed
for the mdx mouse, we also included this muscle in the analysis of
both animal models. MiRNA-expression levels were quantified by
absolute Q-PCR analysis. The statistical analysis confirmed the
miRNA-dysregulation observed in the mdx muscle fibres in single
muscle fibres isolated from SOL, EDL and DIA of a -Sgca null
mice. The only exceptions are represented by miR-206, miR-
199a-5p and miR-17 whose dysregulation depended on the muscle
considered (Figure 3A). In the case of the FRG1 over-expressing
mice, only 4 of the tested miRNAs were found over-expressed in
all muscle analyzed (miR-206, miR-223, miR-199a-5p and miR-
199b), while the remaining 10 miRNAs showed a heterogeneous
behaviour depending on the muscle considered. In particular, the
dysregulation was limited to miR-199b*, miR-31, miR-142-5p and
miR-221 in dystrophic TPZ; to miR-128a, miR-21, miR-221 and
miR-35-5p in dystrophic DIA; and to miR-15b, miR-17, miR-27a,
miR-142-5p, miR-128a, miR-335-5p, miR-21, miR-31 in dystro-
phic VA (Figure 3B). Basing on data mentioned above, the
muscular miRNAs here evidenced are independent from the
genetic defects of MDs and strongly correlate with chronic
damage. The only exception is down-regulation of miR-17 that is
specific of dystrophic single muscle fibres isolated from adult mdx
mouse, suggesting its involvement in compensatory mechanisms
triggered in the early-stage disease of this animal model of DMD.
In fact, newborn mdx mice were characterized by normal
expression levels of miR-17.
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Figure 2. Dystrophin absence is not responsible for the over-expression of several muscle-enriched miRNAs in the mdx mouse. (A)
MiRNAs that were observed over-expressed in the adult mdx mouse (3K months-old) by the array analysis were quantified by Q-PCR in single fibres
isolated from the hind limb of newborn mdx (n = 10) and c5bl (n = 10) mice. The absolute quantity (pg) of each miRNA was represented in the
histogram as white columns for single fibres of c57bl mice and black bars for dystrophic muscle fibres. Single fibres of newborn mdx mice were
characterized by control levels of muscle-enriched miRNAs, demonstrating no correlation with the genetic defect of DMD. (B) MiRNAs that were
observed over-expressed in the adult mdx mouse (3K months-old) by the array analysis were quantified by Q-PCR in single fibres isolated from the
TA, DIA and VA of 6 months-old mdx mice and normalized on control samples. In the table were represented the fold change values of tested
miRNAs in myofibres of 3K and 6 months-old mdx mice in comparison to c57bl myofibers. Tested miRNAs showed a heterogeneous behaves
depending on the muscle type and/or disease progression. (Two-wail parametric t-test; p value ,0, 05 **p value ,0, 01 ***p value ,0,001).
doi:10.1371/journal.pone.0043464.g002
Figure 3. Different MDs are characterized by the same muscle-enriched miRNA-dysregulation. MiRNAs that were observed over-
expressed in the adult 3K months-old mdx mouse by the array analysis were quantified by absolute Q-PCR in single fibres isolated from EDL, SOL
and DIA of a-Sgca null mice (A) and in single fibres isolated from TPZ, DIA and VA of FRG1 high over-expressing mice (B). MiRNAs average fold
changes in muscle fibres of a-Sgca null mice (A) and of FRG1 over-expressing mice were shown in the tables in a linear scale. Tested miRNAs were
similarly dysregulated in the animal model of different MDs. (Two-tail parametric t-test; *p value ,0, 05; **p value ,0, 01; ***p value ,0,001).
doi:10.1371/journal.pone.0043464.g003
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Acute and Chronic Muscle Damage Recruits
Different Set of miRNAs in Single Muscle Fibres with a
Common Over-expression of miRNA 206
In order to further investigate muscle damage and to correlate
miRNAs to muscle regeneration, we experimentally produced a
controlled skeletal muscle injury by injecting CTX into TA of
C57BL mice. By this approach, the induced damage mainly causes
necrosis and consequent regeneration of fibres. Control mice
(n = 10) were injected at day 0 and sacrified at 2, 5, 7, 10 days after
injury. Before 2 days after CTX delivery, mice were not sacrified
because there is evidence of extensive myonecrosis and edema of
muscle fibres, which makes impossible the isolation of single fibres
and the avoidance of non muscle cell contamination. Within 2
days a hypercellular response is observed, muscle regeneration is
evident within 5 days from injury and by day 10 the architecture of
the muscle is largely restored [39]. Since MDs are considered two-
tired diseases where acute muscle damage is accompanied by low
chronic background damage [14], we restricted the analysis to
miRNAs previously associated to dystrophic muscle fibres. Single
muscle fibres were isolated from injected and controlateral TA at
each time point and miRNAs were quantified by absolute Q-PCR
analyses. Data obtained evidenced a group of miRNAs whose
expression does not change during muscle repair afterwards acute
damage (miR-15b, miR-17, miR-128a, miR-221, miR-199a-5p
miR-199b and miR-199b*) (Table 1), and a group of miRNAs that
are triggered afterwards CTX delivery (miR-206, miR-31, miR-
21, miR-335-5p, miR-27a, miR-142-5p and miR-223) (Table 1),
suggesting major involvement of the latter in muscle regeneration.
Interestingly the expression of miR-199b was not triggered by
acute muscle damage, further supporting the strong correlation
between its expression levels and the accumulation of chronic
muscle damage, as previously demonstrated in the mdx mouse
(Figure 2B). Moreover, miR-17 was not dysregulated afterwards
acute muscle damage, confirming its specific role in the muscle
pathophysiology of the mdx mouse. More importantly, miRNAs
recently associated to muscle regeneration such as miR-31, miR-
206 and miR-335-5p were confirmed over-expressed after acute
damage [16].
New Muscular miRNAs and miRNA-206 are Over-
expressed in DMD Patients
In agreement with data already published characterizing the
miRNome of mdx and DMD muscle [15,16,17], the over-
expression of several miRNAs (miR-21, miR-31, miR-199a-5p,
miR-199b, miR-142-5p, miR-221, miR-223 and miR-335-5p) was
confirmed in murine dystrophic single muscle fibres. Otherwise,
single muscle fibres based-analyses highlighted new miRNAs
(miR-17, miR-27a, miR-128a and miR-199b*) associated to
dystrophic and/or damaged muscle. To verify reliability and
clinical relevance of data obtained from the analysis of murine
dystrophic single muscle fibres, we quantified the expression levels
of miR-17, miR-27a and miR-128a in single muscle fibres
dissected from human biopsies of DMD patients. Since miR-
199b* is mouse-specific, the expression of this miRNA was not
considered for the analyses. Moreover, two further miRNAs were
quantified in human dystrophic fibres: miR-15b, whose over-
expression was formerly observed in the mdx mouse by
Cacchiarelli et al. [17] but not in DMD muscle [15]; and miR-
206, whose expression profile was widely investigated in dystrophic
and damaged muscle with controversial results [15,16,17,34,40].
Single muscle fibres were dissected from the muscle biopsies of 12
healthy subjects and 18 DMD patients with an age range between
1 and 18 y-o (Figure 4A), and expression levels of miR-15b, miR-
17, miR-27a, miR-128a and miR-206 were quantified by absolute
Q-PCR analyses. Data obtained confirmed over-expression of
miR-17, miR-27a and miR-206 in single fibres of DMD muscle
biopsies (Figure 4B and 4C). Otherwise the expression levels of
miR-15b and miR-128a were similar in control and DMD human
muscle fibres (Figure 4B and 4C), as already shown by Eisenberg
et al. [15]. It is important to notice that miR-17 is down-regulated
in muscle fibres of the mdx mouse but over-expressed in single
fibres of DMD patients, further supporting the involvement of
epigenetic during chronic muscle damage. Moreover the up-
regulation of miR-206, which is a myomiR associated to muscle
regeneration, was confirmed in human dystrophic fibres as already
demonstrated by Greco et al [16].
The Regeneration-associated myomiR-206 Down-
regulates a Member of the High-mobility Group Proteins
In order to localize myomiR-206 shown to be up-regulated in
single muscle fibres of animal models of MDs and after acute
damage, we performed in situ hybridization experiments on tissue
slices of TA isolated from the mdx and CTX-injected C57bl mice
(3K months-old). As shown in Figure S3, over-expression of
myomiR-206 was limited to newly formed or regenerating fibres
both in dystrophic and CTX-injected TA, confirming previous
publications [33,34]. These data are also in agreement with
previous works describing several target genes of miR-206 such as
the Connexin43, DNApolI, Utrophin and Pax7 during muscle
regeneration [41,42,43,44]. A target-gene prediction analysis was
performed for myomiR-206 using 6 different computational
algorithms (PITA, TargetScan, PicTar, ElMMo, miRDb and
miRanda). Among the predicted target genes, we found the high
mobility group box 3 (Hmgb3 or HMG4). In particular the
Table 1. Acute muscle damage activates miRNA machinery in
isolated myofibers.
2d 5d 7d 10d
miR-206 21,2 18,2 26,8** 4,5*
miR-31 1 19,5 14,2 9,6***
miR-21 2,7 5,5 12,7** 2,3*
miR-335-3p 1 3,1 8,9* 1,1
miR-27a 1,4 2,7 4,9** 1,7
miR-142-p 3,7* 6,5 8,6 1
miR-223 1 2,6** 1,4 21,8
miR-15b 1,1 1,9 1,4 21,7
miR-17 1,3 1,1 1,1 1,2
miR-128a 22 21,1 21 23
miR-221 21,9 22,8 22 22,8
miR-199a-5p 22,7 1,3 2,2 21,3
miR-199b 21,3 1,1 1,4 1
miR199b* 1,1 21,3 21,2 21,7
Dystrophic-fibres associated miRNAs were quantified by Q-PCR in single fibres
isolated from TA of c57bl mice (n = 10) after CTX-injection. Mice were sacrified
at the day 2, 5, 7, 10 after CTX-injury. In the table are represented the fold
change values of tested miRNAs in CTX-injected muscle compare to
controlateral not injected TA. MiR-206, miR-31, miR-21, miR-335-5p, miR-27a,
miR-142-5p and miR-223 were significantly up-regulated afterwards muscle
damage respect damaged muscle. Otherwise the other 7 miRNAs were not
triggered upon CTX-injection.
(Two-tail parametric t-test; *p value ,0, 05; **p value ,0, 01; ***p value
,0,001).
doi:10.1371/journal.pone.0043464.t001
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potential binding of miR-206 to the 39UTR of Hmgb3 involves
two binding sites (first site goes from nt 575 to nt 585 of Hmgb3-39
UTR; the second site goes from nt 714 to nt 726 of Hmgb3-
39UTR). Hmgb3 is a non-histone, chromatin-associated nuclear
protein that interacts with transcription factors, enhancing the
binding of these transcription factors to DNA and enhancing their
transcriptional activity [30]. Its expression in adult mice was
majorly observed in the bone marrow, where it regulates the
balance of haematopoietic stem cells (HSCs) self-renewal [45,46].
Furthermore Nemeth et al. highlighted an activated Wnt signalling
in Hmgb32/2 HSCs, suggesting an involvement in the regulation
of Wnts members which are fundamental in muscle development,
regeneration and myogenesis [47]. Since the expression of Hmgb3
was not previously investigated in skeletal muscle, we verified by
Western Blot (WB) and qRT-PCR analyses its expression in single
muscle fibres isolated from TA and VA of 3K m-o c57bl mice.
Surprisingly, Hmgb3 protein and mRNA were both easily
detectable in single muscle fibres isolated from adult c57bl mice
(Figure 5A and 5B). In order to verify if Hmgb3 can be modulated
by myomiR-206, we performed functional tests in Hek cells using
a standard luciferase assay. We cloned the 39UTR of Hmgb3
downstream to the Firefly Luciferase reporter gene in the
pmirGLO Dual-Luciferase Expression Vector (Promega, Madi-
son, WI, USA) (PGLO), generating a plasmid (PGLO-Hmgb3)
where the activity of the Firefly Luciferase is under the control of
the 39UTR of Hmgb3. The PGLO contains a constitutively
Figure 4. Identification of new murine dystrophic-fibres associated-miRNAs in muscle biopsies of DMD subjects. (A) The age and type
of muscle of healthy subjects (12) and DMD patients (18) were listed. Moreover the type of muscle from which the biopsies were isolated were also
reported. (B–C) MiR-15b, miR-128a, miR-206, miR-17 and miR-27a were quantified by absolute Q-PCR in muscle biopsies of control and dystrophic
subjects listed in A. The absolute values (pg) of tested miRNAs were represented in the histogram for healthy (white bars) and dystrophic single fibres
(black bars). (B) Quantitative analysis showed that only miR-128a, miR-206 and miR-17 were up-regulated in human dystrophic single fibres
independently of the muscle type. (Two-tail parametric t-test; *p value ,0, 05; **p value ,0, 01; ***p value ,0,001).
doi:10.1371/journal.pone.0043464.g004
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expressed Renilla luciferase gene that is used to normalize the
expression of the Firefly Luciferase, since it is an indicator of the
transfection efficiency. We transiently co-transfected Hek cells with
PGLO-Hmgb3 construct and the relative agonist of miR-206
(mimic-miR-206) (Thermo scientific, Waltham, MA, USA) at a
concentration of 25 nM for 48 h. These experiments evidenced
down-regulation (32%; p value = 0, 0151) of luciferase expression
by co-transfection of Hek cells with PGLO-Hmgb3 and mimic-
miR-206 (Figure 6A), confirming the target prediction. In order to
support these results, we mutated the binding sites of myomiR-206
(n = 2) in the previously cloned 39UTR of Hmgb3 and inserted the
mutated 39UTR of Hmgb3 in PGLO (Promega, Madison, WI,
USA) (PGLO-Hmgb3-Mut). Hek cells were co-transfected with
PGLO Hmgb3Mut and mimic-miR-206 (25 nM) for 48 h. In
these conditions luciferase expression was not significantly down-
regulated compared to PGLO-Hmgb3 transfected cells
(Figure 6A). The same data were obtained when 3T3 cells, which
endogenously express Hmgb3 (data not shown), were transfected
with mimic-miR-206 (25 nM) for 48 h and the expression level of
endogenous Hmgb3 was quantified by qRT-PCR analysis
(Figure 6B). Since myomiR-206 is strongly induced in dystrophic
single muscle fibres, we verified Hmgb3 down-regulation in
dystrophic fibres by performing western blot analyses on muscle
fibres isolated from adult mdx and control mice (Figure 5A). As
shown in figure 5B, densitometric analysis on WB bands evidenced
a decreased expression of Hmgb3 protein in TA and VA
(p= 0.0133) of mdx mice. The same samples were tested for
expression levels of Hmgb3 transcript, confirming down-regula-
tion of Hmgb3 in dystrophic muscle fibres (Figure 5C). Since
myomiR-206 is strongly induced during muscle regeneration and
localizes in regenerating fibres (Figure S3) [17,34], Hmgb3 mRNA
was quantified in single fibres of CTX-injected muscle vs.
controlateral un-injected TA. These experiments highlighted a
strong down-regulation of Hmgb3 upon muscle injury (Figure 6C),
concurrent with induction of myomiR-206 (Table 1), and the
involvement of this target gene during muscle regeneration. To
further verify the role of Hmgb3 in myogenesis, we quantified and
compared Hmgb3 transcript and miR-206 expression in prolifer-
ating C2C12 myoblasts (MB) versus differentiated C2C12 myotubes
(MT) obtained after 7 days of serum-privation (Figure 6D–E).
These experiments evidenced opposite expression profiles of
Hmgb3 and miR-206 during myogenesis. In particular, myotubes
were characterized by low levels of Hmgb3 and high levels of miR-
206 (Figure 6D and 6E). Taken together, these data demonstrate
that up-regulation of miR-206 upon chronic and acute muscle
damage down-regulates Hmgb3 and modifications of the chro-
matin-status can be speculated as down-stream event. Neverthe-
less, specific target genes of Hmgb3 need to be identified in order
to more finely characterize the molecular pathway regulated by
miR-206 through Hmgb3 upon muscle regeneration.
Discussion
Following the discovery of miRNAs, their participation was
investigated in almost all biological processes and, even more
importantly, their central role in gene-expression regulation was
implicated in many human diseases [3,4,5,6,7,8] Regarding this,
in the recent years many efforts were focused to finely characterize
the role of miRNAs in myogenesis, so that now the miRNA
biogenesis is considered necessary for proper muscle development
and a restricted number of miRNAs, known as myomiRs (miR-1,
miR-133, miR-181, miR-206, miR-208), is considered as integral
part of muscle biology [9,11]. Starting from these evidences,
Eisenberg et al. demonstrated that muscle biopsies affected by 10
major primary muscular disorders are characterized by the
dysregulation of several miRNAs, opening the possibility to use
these small RNA molecules as therapeutic targets or potential
biomarkers [15]. Nevertheless more investigation is required to
finely tune myogenesis through the modulation of miRNAs. With
the present study we wanted to identify miRNAs that are
modulated by muscle fibres in response to damage in order to
aloud muscle remodelling and regeneration. This purpose was
reached by analysing the miRNome of muscle fibres isolated from
dystrophic and CTX-injected muscle. Dystrophic muscle is
characterized by progressive muscle wasting and weakness,
representing an animal model of chronic muscle damage, while
CTX-injected muscle is an animal model of acute damage.
Importantly single-fibre based-analysis avoided contamination
from non-muscle tissue, focusing the investigation on resting
(remodelling) and newly-formed (regenerating) muscle fibres. In
the present study three animal models of MDs were taken in
consideration: the mdx mouse, animal model of DMD; the a-Sgca
null mouse, animal model of LMGD-2D; and the FRG1 high
over-expressing mouse, animal model with a dystrophy similar to
FSHD. More in particular, we started by the miRNome of single
fibres isolated from different muscles (TA, DIA and VA) of 3K
months-old mdx mouse. The dysregulated miRNAs associated to
the mdx mouse were then verified during disease progression of
this animal model and in single fibres of a-Sgca null mice (SOL,
EDL and DIA) and FRG1 over-expressing mice (TPZ, DIA and
VA) in order to evaluate their correlation with genetics of tested
dystrophic mice. Dystrophic muscle fibres isolated from different
animal model of MDs were commonly characterized by the over-
expression of several miRNAs (miR-15b, miR-21, miR-27a, miR-
31, miR-128a, miR-142-5p, miR-199a-5p, miR-199b, miR199b*,
miR-206, miR-221, miR-223 and miR-335-5p) with an expression
profile strictly dependent on muscle impairment and damage
accumulation (Figure 7). In support to this, when the dysregulated
miRNAs were analyzed during disease progression of the
dystrophic mdx mouse (newborn, 3K and 6 months-old), their
expression levels were found similar to control levels in newborn
mdx mice and heterogeneously modulated among the different
muscles of older mdx mice, reflecting the heterogeneous distribu-
tion of muscle impairment. Taken together, these evidences also
demonstrate no link between dystrophic miRNA-profile and the
genetic causative defects of the different MDs, excluding the
possibility to use any of the muscular miRNAs mentioned above as
biomarker of a specific MD. Otherwise the over-expression of
these miRNAs might function as a biomarker of chronic muscle
damage. Surprisingly, apart from the regeneration-associated
myomiR-206, no known myomiRs were found dysregulated in
dystrophic single muscle fibres. Otherwise a group of miRNAs
recently correlated to myogenesis (miR-27a, miR-31, miR-221)
[33,37,38] were confirmed to be mis-modulated in dystrophic
single muscle fibres. In comparison with data already published by
Eisenberg et al. and Greco et al. [15,16], single-fibres based-
analysis allowed the discovery of new muscular miRNAs whose
expression levels are up-regulated in dystrophic murine muscle
(miR-15b, miR-27a, miR-128a and miR-199b*). For this reason
we verified their expression in single muscle fibres isolated from
biopsies of DMD patients. Analyses were also extended to
myomiR-206 since its up-regulation in human dystrophic muscle
was only confirmed by Greco et al. and not by Eisenberg et al.
[15,16]. MiRNAs were quantified in human muscle fibres of 12
control subjects and 18 DMD patients, confirming the over-
expression of miR-17, miR-27a and miR-206 in diseased muscle.
In order to investigate the relationship between miRNAs
associated to dystrophic muscle and muscle regeneration, we
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induced a controlled skeletal muscle injury by injecting CTX in
TA of control mice. Only 7 of the 14 miRNAs associated to
dystrophic fibres (miR-206, miR-31, miR-21, miR-335-5p, miR-
27a, miR-142-5p and miR-223) were triggered by CTX injury.
We hypothesized that acute CTX damage triggers the expression
of these miRNAs, while chronic-damage associated-miRNAs may
be activated by other compensatory mechanisms participating to
deterioration of resting dystrophic fibres. MyomiR-206 is one of
the most investigated myomiRs in skeletal muscle tissue [40]. Like
miR-133b, its expression is regulated by MEF2 and MyoD
[41,42]. It was found to promote muscle differentiation by, in part,
inhibiting a component of DNA polymerase [41] as well as
follistatin-1 (Fstl1) and utrophin (Utrn), genes that are suppressed
in fibroblasts converted to skeletal muscle cells [42]. It was also
shown to regulate skeletal muscle satellite cell proliferation and
differentiation by repressing paired box gene 7 (Pax7), which is
fundamental for regulation of myogenesis [44]. As previously
described [17,34] we demonstrate dysregulation and in situ
localization of miR-206 in regenerating single fibres. Nevertheless
the big limitation in understanding its biological function and
application in the field of therapeutics, lies on only few validated
target genes that are downstream players in important pathways.
For these reasons we performed a prediction-analysis of target
genes and looked for regulators of epigenetic and Hmgb3 was one
of the listed gene. Hmgb3 is a member of the HMG superfamily
which is the most abundant non-histone proteins in the eukaryotic
nucleus [30]. In particular it is classified with Hmg-3 and -2 into
Hmg-box subfamily, defined by the presence of DNA-binding
Hmg-box domains [30]. Up to now its expression was majorly
localized to the bone-marrow where it regulates the balance of
HSC, through modulation of Wnt-signalling [45]. In particular
Hmgb32/2 HSCs were characterized by increased levels of Wnt
signalling; members of the Wnt family are involved in various
stages of skeletal muscle development and regeneration [47]. For
this reason we investigated the expression of Hmgb3 in single
fibres isolated from TA and VA of control mice and confirmed its
expression in the skeletal muscle. Furthermore, experiments
performed on muscle fibres isolated from dystrophic TA, VA
and CTX-injected muscle, confirmed that Hmgb3 is down-
regulated consequently to acute and chronic muscle damage
mirrored to myomiR-206. Basing on these experimental evidenc-
es, we performed in-vitro luciferase assays confirming an inhibitory
effect of myomiR-206 on Hmgb3. In order to further demonstrate
the involvement of Hmgb3 in myogenesis, its expression levels
were evaluated during differentiation of C2C12 into myotubes and
a strong down-regulation of Hmgb3 was observed mirrored to
myomiR-206. These results together with data already published
demonstrating modulation of Wnt family members upon C2C12
cells differentiation [47], support a possible correlation of Hmgb3
expression levels with Wnt signalling in skeletal muscle, as already
demonstrated for HSCs [45]. Furthermore, since Hmgb3 is non-
histone, chromatin-associated nuclear protein that interacts with
transcription factors enhancing their transcriptional activity,
myomiR-206 might participate to muscle regeneration by
sculpting the chromatin and regulating the transcription of several
genes, like Wnts. In conclusion the present study provides a
detailed image of muscular miRNAs that are expressed in single
muscle fibres and are modulated in a condition of acute and
chronic muscle damage. Importantly the analysis of single muscle
fibres guaranteed no contaminations from surrounding tissues,
enabling the identification of a subset of miRNAs that are actually
linked to muscle remodelling and could be a target for recovery.
Furthermore the analyses of single fibres enabled the discovery of
new muscular miRNAs and did not evidence the dysregulation of
many others, underlining the importance to accurately select the
starting material for the analysis of miRNAs in biological
processes. In this study we have also shown the expression of
non-muscle enriched miRNAs, such as the granulocytes-associated
miR-223 and haematopoietic miR-142-5p, in single muscle fibres.
In agreement with our finding, previously published data
demonstrated expression of miR-223 and miR-142-5p not limited
to granulocytes or haematopoietic lineage. In particular, miR-223
was localized in cardiomyocytes, with prominent peri-nuclear
staining, and in non-myocytes by in situ hybridization on
cryosection of heart [48]; and miR-142-5p was detected in
embryonic stem cells (ESC) where it is involved in cardiac
differentiation [49]. Moreover expression of miR-223 and miR-
142-5p in single muscle fibres might reflect the common
mesodermic origin of muscle and hematopoietic tissues. In support
to this: miR-335 and miR-21 were found in human mesenchymal
stromal cells [50] and in mesenchymal stem cells (MSCs) together
with miR-21, miR-27a, miR-128a, miR-199b [51] miR-15b, miR-
17, miR-21, miR-27a, miR-31, miR-199a, miR-199b, miR-221
and miR-335-5p were found in MSCs and in MSC secreted
Figure 5. Hmgb3 expression-pattern in single fibres. (A) Immunoblotting experiments confirmed the presence of Hmgb3 protein in single
muscle fibers isolated from the TA and VA of c57bl (n = 3) and mdx (n = 3) mice. (B) Densitometric analysis on WB bands evidenced a decreased
expression of Hmgb3 in the TA and VA (p= 0.0133) of mdx mice. (C) Quantification of Hmgb3 mRNA by qRT-PCR in single fibres isolated from the TA
and VA of mdx mice (n = 10) and of c57bl (n = 10) mice confirmed a down-regulation of Hmgb3 in dystrophic muscle. (Two-tail parametric t-test; *p
value ,0, 05; **p value ,0, 01; ***p value ,0,001).
doi:10.1371/journal.pone.0043464.g005
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microparticles [49,52,53]. In conclusion we suggest for the first
time that Hmg-box family transcription factors, previously linked
to biological hematopoietic circuits, is also part of the pathways
controlling muscle regeneration. Identification of genes controlled
by myomiR-206 through Hmgb3 can be instrumental to explain
the molecular mechanisms involved in myomiR-206 mediated
muscle regeneration in muscular dystrophy and muscle damage.
Materials and Methods
Ethics Statement
Mice were obtained from Charles River Laboratories (Calco,
Italy), from Dr Cossu and Gabellini Labs (San Raffaele Hospital,
Milan, Italy). All procedures involving living animals conformed to
Italian Country law (D.L.vo 116/92 and subsequent additions).
Human samples were collected after signed informed consent from
all participants according to the guidelines of the Committee on
the Use of Human Subjects in Research of the Fondazione
IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano
(Milan, Italy) and after approval of the ethics committee of the
University of Milan, Italy (CR937-G) which also authorized the
use of animals for this study.
All cell lines were commercially obtained from ATCC: C2C12:
ATCC number CRL-1772, NIH-3T3: ATCC number CRL-
1658, and HEK293: ATCC number CRL-1573.
Animal Models
Newborn-, 3K m-o and 6 m-o dystrophic mdx mice and
C57BL mice obtained from Charles River Laboratories (Calco,
Italy), 4 m-o a-Sgca null mice given from Dr Cossu and 4 m-o old
FRG1 over-expressing mice offered by Dr Gabellini were used
throughout this study.
Figure 6. MyomiR-206 modulates Hmgb3 expression during myogenesis. (A) Hek cells were co-transfected with mimic-miR-206 at a
concentration of 25 nM for 48 h and with pGLO-control or pGLOHmgb3 or pGLOHmgb3Mut. MiR-206 down-regulated the expression of luciferase of
32% (p= 0, 0151) in Hek cells co-transfected with pGLOHmgb3. Instead no down-regulation happened when the binding site of miR-206 was
mutated. (B) 3T3 cells were transfected with mimic miR-206 at a concentration of 25 nM for 48 h, evidencing a strong down-regulation of
endogenous Hmgb3 mRNAs. (C) Quantification of Hmgb3 mRNA by qRT-PCR in single fibres isolated from CTX-injured TA at day 2, 5, 7 and 10 from
the injection evidenced a strong down-regulation of Hmgb3 during muscle regeneration. (D–E) Hmgb3 mRNA (D) and miR-206 (E) were respectively
quantified by relative qRT-PCR and by absolute Q-PCR in proliferating C1C12 myoblasts cell line (MB) versus differentiated C1C12 myotubes (MT). The
quantification analysis highlighted an opposite expression trend for Hmgb3 and miR-206, further validating inhibition of Hmgb3 by miR-206
(AU= arbitrary units). (Two-tail parametric t-test; *p value ,0, 05; **p value ,0,01; ***p value ,0,001).
doi:10.1371/journal.pone.0043464.g006
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Human Samples
Muscle biopsies from DMD (n= 18) and control subjects
(n = 12) were collected. All dystrophic patients (n = 18) had a
diagnosis of DMD based on the absence of dystrophin
immunoreactivity on biceps and quadriceps muscle sections
and based on PCR genotyping. None of the participants at the
time of biopsy was treated with corticosteroid drugs. All control
subjects included in this study presented at the time of the
biopsy a suspect metabolic disorder not confirmed by biochem-
ical and histopathological studies. Control biopsies did not show
signs of muscle pathology on histological and histochemical
examination. All bioptic specimens used in this study were
taken, for diagnostic purposes, under institutionally approved
protocols. Since all our patients were minors, their parents were
asked to sign an informed consent disclosing future use of the
bioptic material for research.
Single Fibres Extraction
This study was approved by ethics committee of the University
of Milan, Italy (CR937-G). Mice were killed by cervical dislocation
and vastus (VA), diaphragm (DIA), tibialis (TA), extensor
digitorum longus (EDL), soleus (SOL) and trapezius (TPZ) were
carefully dissected away from the surrounding musculature. Single
fibres were isolated by dissected muscles as described in Bischoff
Figure 7. Expression profile of miRNAs associated to dystrophic single muscle fibres. (A) The expression profiles of miRNAs associated to
dystrophic fibres of mdx, a-Sgca null and FRG1 over-expressing mice are reported as over-expressed (red block), down-regulated (green block) or
similarly expressed (white block) to normal C57/BL fibres. (B) MiRNAs whose dysregulation in dystrophic fibres of mdx, a-Sgca null and FRG1 over-
expressing mice depended on the muscle-type are listed in the red circle. Otherwise, miRNAs that were mis-modulated in dystrophic fibres of mdx, a-
Sgca null and FRG1 over-expressing mice independently to the muscle-type are listed in the pink circle.
doi:10.1371/journal.pone.0043464.g007
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et al. [54]. From freshly isolated fibres, total RNA extraction was
performed using TrizolReagent (Invitrogen, Life Technologies,
Carlsbad, California, USA), as described the manufacturer’s
protocol.
MiRNA Array Analysis
Single muscles fibres were isolated from TA, DIA and VA of
mdx (n= 3) and c57bl normal (n = 3) mice. Isolated muscle fibres
were frozen in liquid nitrogen-cooled isopentane and shipped to
Miltenyi Biotec (Bergisch Gladbach, Germany). RNA extraction
of single myofibres, microarray data processing and analysis was
performed by Miltenyi Biotech. (Bergisch Gladbach, Germany).
Total RNA was isolated using TrizolReagent (Invitrogen, Life
Technologies, Carlsbad, California, USA) as described the
manufacturer’s protocol. The quality of total RNA samples was
checked by applying the RNA Integrity Number (RIN) which is
calculated by a proprietary algorithm of the Agilent 2100
Bioanalyzer expert software. As hybridization control the Univer-
sal Reference provided by Miltenyi Biotec GmbH was used.
Fluorescence signals of hybridized PIQORTM Microarrays were
detected using a laser scanner from Agilent (Agilent Technologies).
Low-quality spots were flagged and excluded from data analysis.
Unflagged spots were analysed with the PIQORTM Analyzer
software. For statistical analysis the Two-class SAM (Significance
Analysis of Microarrays) method was used. All data are MIAME
compliant and raw data has been deposited in GEO database
(http://www.ncbi.nlm.nih.gov/geo/query; accession number
GSE21219).
Quantification of miRNAs by Absolute (Q-PCR) and
Relative (qRT-PCR) Real-Time PCR Analysis
RNA extraction was performed from single fibres isolated
from TA, VA and DIA of mdx mice (3K and 6 m-o) (n = 10);
from EDL, SOL and DIA of a-Sgca null mice (n = 10); from
VA, DIA, and TPZ of FRG1 over-expressing mice (n = 10);
from single muscle fibres isolated from muscle biopsies of 12
control subjects and 12 DMD patients; from proliferating and
differentiated C2C12 cell lines. Total RNA was extracted with
TrizolReagent as described by the manufacturer’s protocol
(Invitrogen Life Technologies, Carlsbad, California, USA).
TaqMan MicroRNA Assays (Applied Biosystems, Austin, USA)
was used to detect and accurately quantify mature miRNAs
using PTC200 Chromo4 MJ Research instrument (Biorad
Laboratories, Hercules, CA, USA). Aliquots of total RNA
(10ng) were used to analyze miR-1, miR-133a, miR-181b, miR-
15b, miR-17, miR-128a, miR-142-5p, miR-335-5p, miR-31,
miR-206, miR-21, miR221, miR-223, miR-199a-3p, miR-199a-
5p, miR-199b and miR27a by absolute Real-Time PCR (Q-
PCR) using the TaqMan MicroRNA Assays (Applied Biosys-
tems, Austin, USA). In order to obtain an absolute quantifica-
tion, we synthesized RNA oligonucleotides (MWG-Biotech,
Ebersberg, Germany) with the same sequence of muscle
miRNAs that were listed above. 10 ng of the synthetic miRNAs
were retrotranscribed and 10 serial dilutions (1:5) of cDNA
corresponding to 10 ng, 2 ng, 400 pg, 80 pg, 16 pg, 3.2 pg,
0.64 pg, 0.128 pg, 0.0256 pg and 0.0051 pg prepared from
oligonucleotides were analyzed by Q-PCR. The calibration
curve was used to obtain the quantity of miRNAs contained in
each muscle sample. Samples were also tested for the expression
of small RNA U6 (U6sn RNA) using the TaqMan MicroRNA
Assays (Applied Biosystems, Austin, USA) in order to evaluate
the quality and quantity of starting RNA: all tested samples
differed maximum of two CT when analyzed for RNAU6,
demonstrating comparable quantity of starting RNAs. Further-
more, each time we performed an absolute Q-PCR analysis to
evaluate the expression profiles of miRNAs, we also evaluated
in the same plate the expression levels of RNAU6. Each
experiment was performed three times and for each sample, the
median value between the three experiments was reported.
Analysis of statistical significance was determined by two-tail
paired-t-test (Two-wail parametric t-test; p value ,0, 05 **p
value ,0, 01 ***p value ,0,001).
Relative Quantification of Hmgb3 by Real-Time PCR (qRT-
PCR)
For quantification of Hmgb3 and GAPDH, total RNA (1 mg)
obtained from whole muscle, single fibres, proliferating and
differentiated C2C12 cell line were treated with DNAse-RNAse
free for 1 h at 37uC (Promega, Madison, WI, USA) in order to
avoid amplification of genomic DNA. Dnase-treated RNAs were
restrotranscribed by using Super Script First Strand Synthesis
System III for RT-PCR (Invitrogen, Life Technologies) with
oligo(dT)16 primers. cDNA (1.5 ml) was subjected to qRT-PCR
using PTC200 Chromo4 MJ Research instrument (BioRad
Laboratories, Hercules, CA, USA). qRT-PCR was performed in
20 ml volumes using FluoCycle SYBR Master Mix (Euroclone,
Milan, Italy). All PCR assays were performed in triplicate and the
data were pooled. Before using the DCT method for relative
quantification [55], we performed a validation experiment to
demonstrate the efficiency of the primers of the target genes. The
reaction conditions were as follows: 95uC for 10 min; followed by
50 cycles at 95uC for 15 s (denaturation) and 60uC for 1 min
(annealing and elongation). After each experiment Melting Curve
from 55.0uC to 95.0uC, ready every 0.5uC was performed.
Threshold cycle numbers (CT) were determined using MJ
OpticonMonitor Analysis Software and transformed using the
DCT (22DCT) comparative method [54]. The data were showed as
normalized expression (22DCT). Briefly, the DCT value is
determined by subtracting the average GAPDH CT value from
the average of the CT value of the target gene for the same sample.
Gene-specific expression values were normalized to expression
values of GAPDH gene (endogenous control) within each sample.
The sequences of the primer were.Mouse GAPDH F: 59
GTGGCAAAGTGGAGATTGTTGCC 39Mouse GAPDH R:
59 GATGATGACCCGTTTGGCTCC 39.Mouse HMGB3 F: 59
CCGGCATGAGAAGTGTTTGGA 39.Mouse HMGB3 R: 59
TGCGTTTAGGTCCAGAGGGTT 39.
Acute Muscle Damage Experiments
For acute muscle damage assay, injury was performed in 3K
month-olds c57bl mice by injecting 100 ml of 10 mM CTX in TA,
as previously described [25]. Mice were sacrificed at 2, 5, 7 and 10
days post-injection (10 mice per each time point). Serial sections of
10 mm in thickness were used for in-situ hybridization (ISH) and
were stained with Hematossin & Eosin (H&E).
In situ Hybridization
In situ hybridization was performed using a locked nucleic acid
(LNA) detection probe for mmu-miR-206 (Exiqon, Vedbaek,
Denmark), which was labelled with digoxigenin [31] using a DIG
oligonucleotide tailing kit (Roche, Milano, Italy). Tissue slices of
TA of 3K month-olds mdx mice and CTX-injected tibialis of
c57bl mice were fixed with 4% paraformaldehyde (PFA) in PBS,
were immersed in 100% methanol, rehydrated, treated with
proteinase K, and then re-fixed with PFA. After stringent wash at
55uC in 50% formamide, 26SSC and then PBS, they were
incubated with blocking solution, followed by alkaline phospha-
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tase-conjugated anti-DIG antibody (Roche, Milano, Italy). Hy-
bridized probes were detected and visualized by colour reaction
with alkaline phosphatase substrate kit red (Vector Labs,
Burlingame, CA, USA).
Prediction of Potential Target Genes of the Differentially
Regulated miRNAs
Using different computational approaches it is possible to
predict potential binding sites for miRNAs in the genome,
evidencing potentially regulated mRNAs. The predicted targets
usually are identified based on the presence of a 6-8bp target site
(or ‘‘nucleus’’) for the respective miRNA mainly located in the
39UTR of the mRNA. Although the various target prediction
approaches consider additional features like evolutionary conser-
vation of the target sites, structural target site accessibility, and
minimum free energy of the local miRNA/mRNA interaction, the
number of potential targets per miRNA is still high. The miRNAs
with significant expression differences between dystrophic and wild
type muscle samples were subjected to various target prediction
algorithms which are publicly available (PITA, TargetScan,
PicTar, ElMMo, miRDb and miRanda). Each of the algorithms
returns several hundreds of potential targets for each miRNA
which would sum up to several thousands potential targets of all
differentially regulated miRNAs identified in this project.
Evaluation of Hmgb3 Protein Expression by Western Blot
Analysis
Single fibres and whole muscles were lysed directly in 16
sample buffer (1% SDS) containing 2 mg/ml aprotinin, 10 mg/ml
leupeptin, 10 mM sodium fluoride (NaF), 1 mM sodium vanadate
(Na3VO4) and 1 mM phenylmethylsulfonylfluoride (PMSF). Ly-
sates were boiled 5 min and centrifuged at 100006g for 5 min to
remove insoluble material. Total protein concentration was
determined according to Lowrys method and lysates were stored
at 220uC. Samples were analyzed on 7.5% polyacrylamide gel,
transferred to supported nitrocellulose membranes (BioRad
Laboratories, Hercules, CA, USA), and the filters were saturated
in blocking solution (10 mM Tris, pH 7.4, 154 mM NaCl,
1%BSA, 10% horse serum, 0.075%Tween-20) overnight at 4uC.
Primary antibodies anti-Hmgb3 (RD systems Inc., Newcastle,
USA) and anti-b-actin (Sigma, Milan, Italy) were incubated for
90 min at room temperature and then followed by washing,
detection with horseradish peroxidase (HRP) conjugated second-
ary antibodies (DakoCytomation, Carpinteria, CA, USA), and
developed by enhanced chemiluminescence (ECL) (Amersham
Biosciences, Piscataway, NJ, USA). Prestained molecular weight
markers (Bio-Rad Laboratories, Hercules, CA, USA) were run on
each gel. Bands were visualized by autoradiography using
Amersham Hyperfilm (Amersham Biosciences, Piscataway, NJ,
USA).
Luciferase Assay
The murine Hmgb3-39UTR region was obtained by 3T3 cells.
Total RNA was extracted using TrizolReagent as previously
described (Invitrogen, Life Technologies, Carlsbad, California,
USA) and first-strand cDNA was prepared starting from 2ug total
RNA with 50 mM oligo-dT primers using Super Script III First
Strand Synthesis System for RT-PCR (Invitrogen, Life Technol-
ogies, Carlsbad, California, USA). PCR reactions was carried out
with a final mix constituted by 16HF Phusion buffer, 0.2 mM
dNTPs mix, 1 unit of the Phusion High-fidelity DNA Polymerase,
10 pMol of forward primer (59CTCGAGGACACATCTCT-
TATTTGAGTC39), and 10 pMol of reverse primer (59GTCGA-
CACATTTCAGCATTCTAAACATAC39) containing a XhoI
and SalI restriction site respectively. Thirty-five cycles of
amplification were used. The PCR product was cloned into the
pmiRGLO Dual-Luciferase Expression Vector (Promega, Madi-
son, USA). The sequences were always verified by sequencing.
The predicted miR seed sites were mutated using the Quick-
Change Multisite mutagenesis kit (Stratagene, Santa Clara,
California, USA) with the following mutagenic primers:miR-
206.1 F: 59 GGCATAGCATTCTGCGGCCGGCAT-
TAGTTGTGGAAAGG 39miR-206.2 F: 59 CCTAAACG-
CAATTTGCAGACGCATGTTATTTTTTGTATG 39.
Mutations were confirmed by sequence analysis. The wild-type
and mutated 399UTRs (respectively referred as pGLOHmgb3 and
pGLOHmgb3-Mut) were subcloned into XhoI- SalI site of the
pGLO (Promega, Madison, USA).
Hek Transfection with mimic-miR-206 and Luciferase
Assay
Hek cells were maintained in DMEM supplemented with 10%
FBS and penicillin-streptomycin. Hek cells were seeded at 1.36105
cells per well of a 24-well plate and grown for 20 h. pGLOHmgb3
reporter plasmid or its mutants were co-transfected with mimic-
miR-206 (Thermo scientific, Waltham, Massachusetts) at a final
concentration of 25 nM using Lipofectamine 2000 (Invitrogen,
Life Technologies, Carlsbad, California, USA). The transfection
mixtures for each sample contained 2 ml of Lipofectamine
(Invitrogen, Life Technologies, Carlsbad, California, USA),
25 nM of mimic (Thermo scientific, Waltham, Massachusetts)
and 1.5 mg of pGLO or pGLOHmgb3 or pGLOHmgb3-Mut in
100 ml total volume of DMEM (Gibco, Life Technologies,
Carlsbad, California, USA) without antibiotics and FBS (Gibco,
Life Technologies, Carlsbad, California, USA). These reporter
plasmids contained Renilla Luciferase gene that was considered
for normalizing the transfection. Cells were collected 48 h after
transfection, and luciferase activity was measured using a dual-
luciferase reporter assay system with a GloMax luminometer
(Promega, Madison, USA).
3T3 Transfections with mimic-miR-206
3T3 cells were seeded 16105cells per well of a 24-well plate and
grown for 20 h in DMEM supplemented with 10% FBS and
penicillin-streptomycin. The cells were transfected with mimic-
miR-206 (Thermo scientific, Waltham, Massachusetts) at a final
concentration of 25 nM using Lipofectamine2000 (Invitrogen, Life
Technologies, Carlsbad, California, USA). 48 h after transfection,
cells were collected and total RNA was extracted using
TrizolReagent as previously described (Invitrogen, Life Technol-
ogies, Carlsbad, California, USA). Total RNA obtained from
whole muscle and single fibres were treated with DNAse-RNAse
free (Promega, Madison, WI, USA) in order to avoid amplification
of genomic DNA. First-strand cDNA was prepared by using Super
Script III First Strand Synthesis System for RT-PCR (Invitrogen,
Life Technologies, Carlsbad, California, USA), starting from 1 mg
total RNA with 50 ng random hexamer primers. Hmgb3
expression levels were quantified by qRT-PCR analysis in
transfected and non-transfected 3T3 cells.
Supporting Information
Figure S1 Quantification of miRNAs by absolute Q-PCR
analysis. The miRNAs signature was confirmed by absolute Q-
PCR analysis. The analysis was also extended to miR-1, miR-133
and miR-181. Expression profile of evaluated miRNAs in the TA
(A), DIA (B) and VA (C) of 3K months-old c57bl (white columns)
Hmgb3 Determine Muscle Regeneration
PLOS ONE | www.plosone.org 13 August 2012 | Volume 7 | Issue 8 | e43464
and mdx mice (black columns) are shown. (Two-tail parametric t-
test; *p value ,0, 05; **p value ,0, 01; ***p value ,0,001).
(JPG)
Figure S2 Quantification of miRNAs by relative qRT-
PCR analysis. The miRNAs signature was confirmed by relative
qRT-PCR analysis. The analysis was also extended to miR-1,
miR-133 and miR-181. Expression profile of evaluated miRNAs
in the TA (A), DIA (B) and VA (C) of 3K months-old c57bl (white
columns) and mdx mice (black columns) are shown. (Two-tail
parametric t-test; *p value ,0, 05; **p value ,0, 01; ***p value
,0,001).
(TIF)
Figure S3 Expression and localization of miR-206 in
damaged and dystrophic muscle. H&E staining (A) and
miR-206 in situ hybridization (B), performed on serial sections of
TA dissected from 3K months-old mdx mice, are shown. H&E
staining (C, E, G, I) and miR-206 ISH on serial sections (D, F, H
and L) of CTX-injected control TA after day 2 (C, D), 5 (E, F), 7
(G, H) and 10 (I, L) after injury are reported. In situ hybridization
analysis showed intense signals of miR-206 in newly formed
muscle fibres with centralized nuclei, or regenerating fibres, in
both models of muscle damage.
(TIF)
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